Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma
复制标题
DOI：
10.1016/j.clml.2022.07.009
复制
发表时间：
2022-11-01
影响因子：
2.7
通讯作者：
Kim, Won Seog
中科院分区：
文献类型：
--
作者：
Yoon, Sang Eun;Cho, Junhun;Kim, Won Seog
我们对15例复发/难治性AITL患者进行了回顾性研究，以评估5-阿扎胞苷的作用。用5-阿扎胞苷治疗的患者显示出40%的总反应率，尤其是那些以前接受过
We performed the retrospective study with 15 relapsed/refractory AITL patients to assess the role of 5-azacitidine. The patients treated with 5-azacitidine showed a 40% overall response rate, and especially those who previously underwent